Document is current
Any future updates will be listed below
-
Authors
Zhan, Kexin
Wan, Chuchuan
Wang, Ennan
Huang, Yuankai
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 17 June 2025
First Online: 23 June 2025
Declarations
:
: The ethical approval to conduct the pilot survey, pre-test and main survey was granted by the Ethics Committee of China Pharmaceutical University (Project Number: CPU2019015). All methods of the study were carried out in accordance with the ethical standards of the Ethics Committee of China Pharmaceutical University and the principles of CFDA-GCP and the Helsinki Declaration.
: All authors confirm that they have obtained appropriate consent from any identifiable individuals included in the study, and that the manuscript does not contain any information or images requiring publication consent from third parties. No additional consent for publication is applicable in this study.
: The authors declare no competing interests.
: Written informed consent to participate was signed by all participated.
